PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various HPV-associated cancers, including head and neck cancer, cervical and anal cancers.
2024/11/8 11:27:44
(PDSB:NASDAQ)
Analyst coverage
Streetwise Reports Articles